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Background
Neonates with complex congenital heart disease
(CCHD) often require transcatheter or surgical interven-
tion in the first month of life. Transthoracic 2D/Doppler
echocardiography (2DE) is the diagnostic modality of
choice, but occasionally may be inadequate for surgical
planning. Unresolved pre-operative questions may
require complete delineation of extracardiac vascular
anatomy and/or ventricular volumes. In these cases,
cardiac magnetic resonance imaging and angiography
(CMR/MRA) may be delayed in favor of repeat 2DE
studies, which often remain inconclusive. This approach
may lead to unnecessary costs and has yet to be
formally evaluated.
Methods
A retrospective review of neonates with CCHD who
underwent CMR/MRA (2007-12) was performed to com-
pare the costs of imaging between two groups of patients:
one undergoing CMR/MRA after the initial 2DE but prior
to any additional 2DE studies (Group A), and those with
multiple 2DE studies prior to CMR/MRA (Group B).
Thirty-one patients were identified (median age at CMR/
MRA was 4 days; range 2-25 days). Five patients were
excluded (three without CHD; two without 2DE prior to
CMR/MRA). The number of additional 2DE studies (after
the initial 2DE) performed prior to CMR/MRA in Group
B as compared to Group A ranged from one to three.
A single CMR/MRA study prior to surgical intervention
was obtained in all patients. All CMR/MRA studies were
performed under general anesthesia (provided by a neona-
tologist) without adverse events.
Results
The total cost of cardiac imaging (2DE and CMR/MRA) in
Group A (n = 12) was $26,896 (2DE = $14,603; CMR/
MRA = $12,293). The total cost in Group B (n = 14) was
$50,495 (2DE = $36,153; CMR/MRA = $14,342). In total,
$23,599 less was spent in Group A as compared to Group
B, with a mean per patient cost savings of $1,366 between
the two imaging strategies.
Conclusions
CMR/MRA has been shown to be of incremental benefit
in the preoperative assessment of CCHD. However,
depending on practice patterns and/or local availability
of CMR, a diagnostic approach using multiple/serial
2DE studies is often utilized. This study is the first to
suggest that a strategy involving the earlier use of CMR/
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Table 1 Patient Diagnostic Categories





Coarctation of the Aorta 4
Conotruncal Defects 10
Double Inlet Left Ventricle 1
Heterotaxy syndrome 2
Tricuspid Atresia 2
Multiple Left-Sided Obstructive Lesions 4
Vascular Ring 2
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MRA in the diagnostic algorithm of CCHD patients may
improve cost efficiency and cost savings. Further investi-
gation that includes quantification of the diagnostic
power of both 2DE and CMR/MRA across several con-
genital heart disease states may better define whether
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Figure 1 Cardiac Imaging Cost Comparison Between Groups A
and B.
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